Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

about

Newer beta blockers and the treatment of hypertension.

P2860

Q36514083-83B6D7DC-1421-4F12-95C5-14D011191C3C

P2860

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

Item

http://www.wikidata.org/entity/Q57487964

description

im Juli 1987 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 1987

@uk

name

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@en

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@nl

type

Item

label

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@en

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@nl

prefLabel

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@en

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@nl

P1476

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

@en

P2093

E. M. Vaughan Williams

http://www.w3.org/2001/XMLSchema#string

P2860

The steady state TTX-sensitive ("window") sodium current in cardiac Purkinje fibres

Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists

The multiple modes of action of propafenone.

Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.

Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile

Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium.

Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.

Peripheral vascular effects of beta-adrenoceptor blockade: comparison of two agents.

Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.

Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs.

P304

450-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1552-4604.1987.TB03049.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1987-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

about

P2860

P2860

Bevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577